SBIR/STTR Research Award

Practical high resolution microscopy of uncut, unembedded kidney biopsies

Award identifier 1af36a0047354ea5d43ae2492b5e61ac94eaa8dac43ea5136e541c7a819f6e54Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$956,260

Program and phase

SBIR · Phase II – Direct to Phase II

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
APPLIKATE TECHNOLOGIES, INC.
Proposal award date
2019-09-15
Contract end date
2021-06-30
UEI
ZB4HQTBNJ6D4
Solicitation number
PA16-452
Topic code
400

Research abstract

Project Summary Applikate Technologies has developed Clearing Histology with Multiphoton Microscopy (CHiMP), a novel tissue processing and imaging protocol that provides direct-to-digital images from intact pathology tissue specimens, such as biopsies, without the need for wax embedding, slicing, or scanning of slides. The application of this technology to renal diagnosis is expected to improve considerably our ability to render accurate, cost-effective, and timely diagnoses in patients who suffer from a broad range of kidney problems. It will also expand our ability to study and understand kidney disorders by providing otherwise inaccessible data which can be analyzed with emerging computer analysis tools. The aim of this direct-to-Phase II SBIR proposal is to modify the hardware and software components of CHiMP for application to kidney biopsies and to validate CHiMPandapos;s non-inferiority for renal diagnosis compared to standard protocols and its integration into the renal pathology workflow in a clinical setting. CHiMP has many advantages for general histology, including: Handamp;E-like images familiar to pathologists but with superior image quality, sub-micron effective thickness, and without artifacts common to slide preparation; non- destructive imaging that preserves intact tissue for ancillary molecular analysis and immunohistochemistry; rapid turnaround, with images ready within a few hours of receiving tissue; greatly reduced labor costs; true 3D prospective; and digitized images for remote consultation and machine vision. NIDDK has identified access to human kidney biopsies as an important bottle neck for progress in development of precision medicine for acute and chronic kidney disease. CHiMP directly addresses this by preserving tissue and increasing DNA yields. In addition, this proposal will extend CHiMPandapos;s imaging to include second harmonic generation from collagen, thereby enabling evaluation and quantitation of fibrosis, a key factor in renal health and applicable to other conditions such as liver disease. The specific aims of this proposal are to: 1) modify the CHiMP microscope and tissue cassettes to enable second harmonic generation imaging of collagen in kidney biopsies, 2) collect renal biopsy specimens in a clinical setting and evaluate integration into the clinical workflow and 3) add renal specific visualization features to Stackstreamer, our 3D visualization software, and demonstrate the utility of CHiMP for diagnosis. Successful completion of these aims will set the stage for a Phase III transition to regulatory approval and provide a proven platform for early implementation in select hospitals.Project Narrative Acute Kidney Injury and Chronic Kidney Disease impose a significant global health burden, but access to human tissue for development of novel therapies is extremely limited. Applikate Technologies has developed a powerful tissue processing and imaging technology, Clearing Histology with Multiphoton Microscopy (CHiMP), that enables pathologist review of precious biopsy samples without consuming or destroying tissue, in contrast to current approaches, thus retaining more tissue for research. In addition, CHiMP has significant advantages for clinical application to kidney diseases, including superior image quality, direct visualization of fibrosis, lower costs, direct-to-digital implementation, and fast, same-day diagnosis. This proposal seeks to adapt CHiMP for optimized use with kidney tissue and to validate its significant advantages for clinical implementation.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

6 SBIR/STTR records share this UEI (2014–2023). Reported award amounts total $7,807,172. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.